Press Releases

Induced Pluripotent Stem Cells Industry Poised for 9.1% CAGR Growth by 2028

Revolutionizing Disease Modeling and Medicine: The Ethical and Versatile Potential of Induced Pluripotent Stem Cells (iPSCs)

January 22, 2025

According to the latest study from BCC Research, “Induced Pluripotent Stem Cells: Global Marketsis expected to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

The report analyzes application types, product functions, iPSC generation, and types of iPSC-derived cells and species. Application segments include drug development, toxicity testing, academic research, and regenerative medicine. Product function segments cover molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis. iPSC-derived cell types include hepatocytes, neurons, cardiomyocytes, endothelial cells, and other cells like astrocytes, fibroblasts, and hematopoietic progenitor cells.

The BCC Research report assesses the current market status, future needs, and growth forecasts through 2028.

The report also analyzes market drivers, restraints, challenges and opportunities, and profiles the leading companies, including their business segments, financials, product portfolios, and recent developments. Additionally, it covers emerging technologies, new developments, the regulatory landscape, patent analysis, pipeline analysis, and investment outlook.

The factors driving the global market for induced pluripotent stem cells include:

Growing Prevalence of Chronic Diseases: iPSCs help develop new treatments for chronic conditions like diabetes and heart disease.

Increasing Investments in the Biotech Industry: Significant public and private investments are boosting iPSC research and innovation.

Surging Demand for Personalized Medicines: iPSCs enable personalized therapies tailored to individual genetic profiles.

Increasing Demand for Drug Discovery and Development: iPSCs facilitate drug discovery by creating disease models and testing new drugs.

Request a sample copy of the global market report for Induced Pluripotent Stem Cells.

Report Synopsis

 Report Metric

 Details

 Base year considered

 2023

 Forecast period considered

 2023-2028

 Base year market size

 $3.1 billion

 Market size forecast

 $5.2 billion

 Growth rate

 CAGR of 9.1% from 2023 to 2028

 Segments covered

 Reprogramming Method, Generation Method, Application,   Product Function, iPSC-Derived Cell Type, Species, End Use,   and Region

 Regions covered

 U.S., Europe, Asia-Pacific, and the Rest of the World (RoW)

 Market drivers

  • Growing prevalence of chronic diseases.
  • Increasing investments in the biotech industry.
  • Surging demand for personalized medicines.
  • Increasing demand for drug discovery and development.

 

Interesting Facts:

  • Scientists use iPSC-derived cells to test medications for safety and effectiveness before human trials; iPSC-derived neurons help evaluate treatments for Alzheimer’s disease and Parkinson’s disease.
  • iPSCs allow researchers to study disease mechanisms, aiding in discovering novel therapies and early cancer biomarkers.
  • iPSC-based human organoids replicate organ structures and functions, enabling disease research and testing of new drugs and treatments.

Market Leaders include:

  • NCARDIA
  • QIAGEN
  • REPROCELL INC.
  • STEMCELL TECHNOLOGIES
  • TAKARA BIO INC.
  • THERMO FISHER SCIENTIFIC INC.
  • ATCC
  • AXOL BIOSCIENCE LTD.
  • BIO-TECHNE
  • FUJIFILM CELLULAR DYNAMICS INC.
  • LONZA
  • MERCK KGAA

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, please contact info@bccresearch.com.    

Induced Pluripotent Stem Cells: Global Markets( BIO135F )
Publish Date: Nov 2024    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.